Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy

ALG8

alpha-1,3-glucosyltransferase 8

ANRIL

antisense noncoding RNA at the INK4 locus

ASO

antisense oligonucleotides

ATM

ataxia-telangiectasia mutated

ATR

ataxia telangiectasia and rad3-related protein

BCA

bicinchoninic acid assay

cALG8

circular RNA of alpha-1,3-glucosyltransferase 8

Co-IP

Co-Immunoprecipitation

DMEM

Dulbecco's Modified Eagle Medium

ELISA

Enzyme-Linked Immunosorbent Assay

FISH

Fluorescence In Situ Hybridization

GAPDH

glyceraldehyde-3-phosphate dehydrogenase

HR

homologous recombination

IC50

half-maximal inhibitory concentration

IRES

internal ribosome entry site

LC-MS

Liquid Chromatography-Mass Spectrometry

mIHC

multiplex immunohistochemistry

NHEJ

non-homologous end joining

PD-1

programmed cell death protein 1

PDAC

Pancreatic Ductal Adenocarcinoma

PD-L1

programmed death-ligand 1

PDO

Patient-Derived Organoid

PDX

Patient-Derived Xenograft

RAP

RNA Antisense purification

RECIST

Response Evaluation Criteria in Solid Tumours

RIP

RNA Immunoprecipitation

RT-qPCR

Reverse Transcription quantitative Polymerase Chain Reaction

SRSF

serine/arginine-rich splicing factor

SRSF1

serine/arginine-rich splicing factor 1

SRSF3

serine/arginine-rich splicing factor 3

SRSF5

serine/arginine-rich splicing factor 5

SRSF7

serine/arginine-rich splicing factor 7

STAT3

signal transducer and activator of transcription 3

TME

tumor microenvironment

UMAP

Uniform Manifold Approximation and Projection

γH2AX

phosphorylated histone H2AX

Comments (0)

No login
gif